Literature DB >> 11044204

Focal segmental glomerulosclerosis associated with mitochondrial cytopathy.

L M Doleris1, G S Hill, P Chedin, D Nochy, C Bellanne-Chantelot, T Hanslik, J Bedrossian, S Caillat-Zucman, J Cahen-Varsaux, J Bariety.   

Abstract

BACKGROUND: The nonspecific lesion of focal segmental glomerulosclerosis (FSGS) can occur as a primary disease or in a variety of secondary settings. In mitochondrial cytopathies (MCs), the phenotypic expression of the disease depends on the degree of cellular dysfunction, and this correlates with the proportion of abnormal mitochondrial DNA in the cells and the dependence of tissues on oxidative metabolism. The most common renal manifestation in MCs is tubular dysfunction; little has been reported about glomerular diseases.
METHODS: Cases of four adult patients with FSGS and MC are reported. Routine histology and mitochondrial DNA analysis were carried out on renal biopsies.
RESULTS: Family history and clinical manifestations in the four patients with FSGS suggested a diagnosis of MC. An A3243G transition in the mitochondrial DNA tRNA(leu(UUR)) was found in lymphocytes and kidney. Glomerular lesions of FSGS were associated with unusual hyaline lesions, which appeared to represent individual myocyte necrosis in afferent arterioles and small arteries.
CONCLUSION: FSGS is a renal manifestation of MCs. The renal lesion can precede other manifestations of the genetic disease by many years. The striking arteriolar lesions in these cases may have resulted in glomerular hypertension and hyperperfusion, leading to secondary epithelial cell abnormalities and, ultimately, FSGS. However, primary epithelial cell dysfunction caused by mitochondrial defects could not be ruled out on morphological grounds. MCs should be considered in cases of so-called primary FSGS, particularly if there is a familial history of diabetes, neuromuscular disorders, or deafness.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044204     DOI: 10.1111/j.1523-1755.2000.00356.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  25 in total

Review 1.  Differential diagnosis of glomerular disease: a systematic and inclusive approach.

Authors:  Lee A Hebert; Samir Parikh; Jason Prosek; Tibor Nadasdy; Brad H Rovin
Journal:  Am J Nephrol       Date:  2013-09-13       Impact factor: 3.754

Review 2.  Neuromuscular and systemic presentations in adults: diagnoses beyond MERRF and MELAS.

Authors:  Bruce H Cohen
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

3.  Respiratory chain deficiency presenting as congenital nephrotic syndrome.

Authors:  Alice Goldenberg; Linh Huynh Ngoc; Marie-Christine Thouret; Valérie Cormier-Daire; Marie-France Gagnadoux; Dominique Chrétien; Catherine Lefrançois; Vanna Geromel; Agnès Rötig; Pierre Rustin; Arnold Munnich; Véronique Paquis; Corinne Antignac; Marie-Claire Gubler; Patrick Niaudet; Pascale de Lonlay; Etienne Bérard
Journal:  Pediatr Nephrol       Date:  2005-01-29       Impact factor: 3.714

4.  Renal manifestations of primary mitochondrial disorders.

Authors:  Josef Finsterer; Fulvio Alexandre Scorza
Journal:  Biomed Rep       Date:  2017-04-12

Review 5.  Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review.

Authors:  M M Löwik; P J Groenen; E N Levtchenko; L A Monnens; L P van den Heuvel
Journal:  Eur J Pediatr       Date:  2009-06-27       Impact factor: 3.183

6.  Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case-control study.

Authors:  P Massin; D Dubois-Laforgue; T Meas; M Laloi-Michelin; H Gin; B Bauduceau; C Bellanné-Chantelot; E Bertin; J-F Blickle; B Bouhanick; J Cahen-Varsaux; S Casanova; G Charpentier; P Chedin; O Dupuy; A Grimaldi; B Guerci; E Kaloustian; A Lecleire-Collet; F Lorenzini; A Murat; H Narbonne; F Olivier; V Paquis-Flucklinger; M Virally; M Vincenot; B Vialettes; J Timsit; P J Guillausseau
Journal:  Diabetologia       Date:  2008-06-26       Impact factor: 10.122

Review 7.  Transforming growth factor-β, bioenergetics, and mitochondria in renal disease.

Authors:  Gabriella Casalena; Ilse Daehn; Erwin Bottinger
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

8.  An autopsy case of chronic progressive external ophthalmoplegia with renal insufficiency.

Authors:  Takashi Yuri; Yaeko Kondo; Keiko Kohno; Yen-Chang Lei; Seika Kanematsu; Maki Kuwata; Toshiji Iwasaka; Airo Tsubura
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

9.  Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro.

Authors:  Gabriela Casalena; Stefanie Krick; Ilse Daehn; Liping Yu; Wenjun Ju; Shaolin Shi; Su-yi Tsai; Vivette D'Agati; Maja Lindenmeyer; Clemens D Cohen; Detlef Schlondorff; Erwin P Bottinger
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-05

10.  Mitochondrial DNA variants in the pathogenesis of type 2 diabetes - relevance of asian population studies.

Authors:  Pei-Wen Wang; Tsu-Kung Lin; Shao-Wen Weng; Chia-Wei Liou
Journal:  Rev Diabet Stud       Date:  2009-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.